Meeting
2022 ASCO Annual Meeting
Impact of cancer susceptibility gene (CSG) mutations in advanced NSCLC (aNSCLC).
Authors
Danielle Klingberg
St. George Hospital, Kogarah, NSW, Australia
Danielle Klingberg , Janene Dalrymple , Milita Zaheed , Craig R. Lewis , Tom John , Chee Khoon Lee
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 9131)
DOI
10.1200/JCO.2022.40.16_suppl.9131
Abstract #
9131
Poster Bd #
117
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Tumor sequencing with germline genetic testing: Identification of patients with hereditary cancer and precision treatment eligibility.
First Author: Scott T. Michalski
Poster
2023 ASCO Annual Meeting
Spectrum of germline pathogenic variants among patients with cancer in Mexico.
First Author: Jose Luis Rodriguez Olivares
Poster
2017 ASCO Annual Meeting
Safety of multiplex gene testing for inherited cancer risk in a fully accrued prospective trial.
First Author: Allison W. Kurian
Poster
2017 ASCO Annual Meeting
Expanded yield of multiplex panel testing in fully accrued prospective trial.
First Author: Gregory Idos